Nasonex and Deafness neurosensory - a phase IV clinical study of FDA data
Summary:
Deafness neurosensory is found among people who take Nasonex, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Nasonex and have Deafness neurosensory. It is created by eHealthMe based on reports of 28,538 people who have side effects when taking Nasonex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
28,538 people reported to have side effects when taking Nasonex.
Among them, 307 people (1.08%) have Deafness neurosensory.
What is Nasonex?
Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 29,656 Nasonex users for its effectiveness, alternative drugs and more.
What is Deafness neurosensory?
Deafness neurosensory is found to be associated with 1,422 drugs and 869 conditions by eHealthMe.
Number of Nasonex and Deafness neurosensory reports submitted per year:
Gender of people who have Deafness neurosensory when taking Nasonex*:
Age of people who have Deafness neurosensory when taking Nasonex *:
Common drugs people take besides Nasonex *:
Common side effects people have besides Deafness neurosensory *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Nasonex and have Deafness neurosensory?
Check whether Deafness neurosensory is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Deafness neurosensory and when was it recovered:
Expand to all the drugs that have ingredients of mometasone furoate monohydrate:
Alternative drugs to, pros and cons of Nasonex:
- Nasonex (29,656 reports)
Common Nasonex side effects:
- Breathing difficulty: 2,891 reports
- Fatigue (feeling of tiredness): 2,501 reports
- Headache (pain in head): 2,244 reports
- Drug ineffective: 2,138 reports
- Asthma: 2,101 reports
- Cough: 2,045 reports
- Pain: 1,923 reports
- High blood pressure: 1,855 reports
Browse all side effects of Nasonex:
a b c d e f g h i j k l m n o p q r s t u v w x y zDeafness neurosensory treatments and more:
- Deafness neurosensory (4,111 reports)
COVID vaccines that are related to Deafness neurosensory:
- Deafness neurosensory in Moderna COVID Vaccine
- Deafness neurosensory in Pfizer BioNTech Covid Vaccine
- Deafness neurosensory in Johnson and Johnson Covid Vaccine
Common drugs associated with Deafness neurosensory:
- Prednisone: 436 reports
- Methotrexate: 435 reports
- Tylenol: 379 reports
- Gabapentin: 344 reports
- Enbrel: 344 reports
- Celebrex: 341 reports
- Oxycontin: 318 reports
- Fosamax: 312 reports
- Nasonex: 307 reports
- Sulfasalazine: 301 reports
All the drugs that are associated with Deafness neurosensory:
- Deafness neurosensory (1,422 drugs)
Common conditions associated with Deafness neurosensory:
- Rheumatoid arthritis: 432 reports
- Osteoporosis: 284 reports
- Pain: 261 reports
- Arthritis: 248 reports
- High blood pressure: 161 reports
- Sleep disorder: 148 reports
All the conditions that are associated with Deafness neurosensory:
- Deafness neurosensory (869 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mometasone furoate monohydrate (the active ingredients of Nasonex) and Nasonex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clobazam and Protein - Urine - 4 seconds ago
- Dymista and Idiopathic Pulmonary Fibrosis - 13 seconds ago
- Glipizide and Antinuclear Factor Positive - 15 seconds ago
- Diuril and Piperacillin drug interaction - 21 seconds ago
- Zoloft and Blood Antidiuretic Hormone Increased - 26 seconds ago
- Penicillin V Potassium and Ketoconazole drug interaction - 30 seconds ago
- Alupent and Suicidal Ideation - 35 seconds ago
- Sitagliptin and Aspartate Aminotransferase Increased - 35 seconds ago
- Nystatin and Metastasis - 36 seconds ago
- Flovent Hfa and Levobunolol Hydrochloride drug interaction - 36 seconds ago